[go: up one dir, main page]

NO20060669L - Modafinilsammensetninger - Google Patents

Modafinilsammensetninger

Info

Publication number
NO20060669L
NO20060669L NO20060669A NO20060669A NO20060669L NO 20060669 L NO20060669 L NO 20060669L NO 20060669 A NO20060669 A NO 20060669A NO 20060669 A NO20060669 A NO 20060669A NO 20060669 L NO20060669 L NO 20060669L
Authority
NO
Norway
Prior art keywords
modulated
modafinil
enantiomerically
modafinilsammensetninger
solvates
Prior art date
Application number
NO20060669A
Other languages
English (en)
Inventor
Matthew Peterson
Orn Almarsson
Mark Oliveira
Magali Bourghol Hickey
Original Assignee
Cephalon Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US10/660,202 external-priority patent/US7927613B2/en
Priority claimed from PCT/US2004/006288 external-priority patent/WO2004078163A2/en
Priority claimed from PCT/US2004/029013 external-priority patent/WO2005023198A2/en
Application filed by Cephalon Inc filed Critical Cephalon Inc
Publication of NO20060669L publication Critical patent/NO20060669L/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C317/00Sulfones; Sulfoxides
    • C07C317/44Sulfones; Sulfoxides having sulfone or sulfoxide groups and carboxyl groups bound to the same carbon skeleton

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Det blir fremstilt ko-krystaller og solvater av racemisk, enantiomert ren og enantiomert blandet modafinil, og flere viktige fysiske egenskaper blir modulert. Løselighet, oppløsning, biotilgjengelighet, doserespons og stabilitet til modafinil kan moduleres for å forbedre effektiviteten i farmasøytiske preparater.
NO20060669A 2003-09-11 2006-02-10 Modafinilsammensetninger NO20060669L (no)

Applications Claiming Priority (11)

Application Number Priority Date Filing Date Title
US10/660,202 US7927613B2 (en) 2002-02-15 2003-09-11 Pharmaceutical co-crystal compositions
US50820803P 2003-10-02 2003-10-02
US54275204P 2004-02-06 2004-02-06
PCT/US2004/006288 WO2004078163A2 (en) 2003-02-28 2004-02-26 Pharmaceutical co-crystal compositions of drugs such as carbamazepine, celecoxib, olanzapine, itraconazole, topiramate, modafinil, 5-fluorouracil, hydrochlorothiazide, acetaminophen, aspirin, flurbiprofen, phenytoin and ibuprofen
US56041104P 2004-04-06 2004-04-06
US57341204P 2004-05-21 2004-05-21
US57917604P 2004-06-12 2004-06-12
US58199204P 2004-06-22 2004-06-22
US58675204P 2004-07-09 2004-07-09
US58823604P 2004-07-15 2004-07-15
PCT/US2004/029013 WO2005023198A2 (en) 2003-09-04 2004-09-04 Modafinil compositions

Publications (1)

Publication Number Publication Date
NO20060669L true NO20060669L (no) 2006-06-02

Family

ID=36763171

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20060669A NO20060669L (no) 2003-09-11 2006-02-10 Modafinilsammensetninger

Country Status (4)

Country Link
EP (1) EP1670753A4 (no)
JP (1) JP4842819B2 (no)
IL (2) IL173575A0 (no)
NO (1) NO20060669L (no)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2400848A4 (en) * 2009-02-26 2012-07-25 Thar Pharmaceuticals Inc CRYSTALLIZATION OF PHARMACEUTICAL COMPOUNDS
WO2013147072A1 (ja) * 2012-03-29 2013-10-03 大鵬薬品工業株式会社 3-(15-ヒドロキシペンタデシル)-2,4,4-トリメチル-2-シクロヘキセン-1-オンの共結晶

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2593809B1 (fr) * 1986-01-31 1988-07-22 Lafon Labor Benzhydrylsulfinylacetamide, procede de preparation et utilisation en therapeutique
KR20090106661A (ko) * 2000-07-27 2009-10-09 테바 파마슈티컬 인더스트리즈 리미티드 결정질의 순수한 모다피닐 및 이의 제조 방법
IL143106A (en) * 2001-05-13 2005-11-20 Chemagis Ltd Process for the preparation of diphenylmethylthioacetamide
WO2004078163A2 (en) * 2003-02-28 2004-09-16 Transform Pharmaceuticals, Inc. Pharmaceutical co-crystal compositions of drugs such as carbamazepine, celecoxib, olanzapine, itraconazole, topiramate, modafinil, 5-fluorouracil, hydrochlorothiazide, acetaminophen, aspirin, flurbiprofen, phenytoin and ibuprofen
FR2849029B1 (fr) * 2002-12-20 2005-03-18 Lafon Labor Procede de preparation et formes cristallines des enantiomeres optiques du modafinil.
AU2003272270A1 (en) * 2003-02-28 2004-09-28 The Regents Of The University Of Michigan Pharmaceutical co-crystal compositions of drugs such as carbamazeptine, celecoxib, olanzapine, itraconazole, topiramate, modafinil, 5-fluorouracil, hydrochlorothiazide, acetaminophen, aspirin, flurbiprofen, phenytoin and ibuprofen

Also Published As

Publication number Publication date
EP1670753A4 (en) 2008-01-02
JP4842819B2 (ja) 2011-12-21
IL173575A0 (en) 2006-07-05
JP2007513867A (ja) 2007-05-31
EP1670753A2 (en) 2006-06-21
IL199140A (en) 2012-07-31

Similar Documents

Publication Publication Date Title
WO2005023198A3 (en) Modafinil compositions
CA2366932A1 (en) Cyclic protein tyrosine kinase inhibitors
EA200501332A1 (ru) Производные пиримидин-4-она и их применение в качестве модуляторов киназы p38
DE60132309D1 (de) Amin-derivate zur behandlung von apoptosis
BR0313176A (pt) Composições de pirazol úteis como inibidores de gsk-3
DK1299348T3 (da) Forbindelser og sammensætninger til levering af aktive midler
NO20061506L (no) Heterocykliske inhibitorer av MEK og fremgangsmater for anvendelse derav
CY1109962T1 (el) Υποκατεστημενες ενωσεις 1,4,8-τριαζασπειρο[4,5]δεκαν-2-ονης για τη θεραπεια παχυσαρκιας
EA200602196A1 (ru) Производные пиразола, композиции, содержащие эти соединения, и способы применения
SE0401970D0 (sv) Novel compounds
DK1546127T3 (da) Nye pyrimidinamidderivater og anvendelse deraf
ATE401875T1 (de) Pharmazeutische feste dispersionen von modafinil- verbindungen
NO20026242L (no) Syntesemetoder for aplidin og nye antitumorale derivater, metoder for deresfremstilling og anvendelse av disse
DE60323765D1 (de) Inhibitoren der 17 beta-hydroxysteroiddehydrogenase des typs 3 zur behandlung androgenabhängiger krankheiten
NO20034386D0 (no) Fast farmasöytisk preparat omfattende 4-cyano-trifluor-3-(4- fluorfenylsulfonyl)-2-hydroksy-2-metylpropiono-m-toluidid og PVP
MEP20908A (en) Thienopyrazoles
DE60142913D1 (de) Arzneilösungen enthaltend modafinilverbindungen
DE602004031410D1 (de) Inden derivate als pharmazeutika
EA200501821A1 (ru) Фармацевтическая комбинация, содержащая модафинил и другой лекарственный препарат
MA27880A1 (fr) Derives de tetrahydrocarbazole et leur utilisation pharmaceutique
NO20064934L (no) Fremgangsmate for fremstilling av et fast, farmasoytisk preparat
NO20064190L (no) Preparat for oral administrering av tamsulosin-hydroklorid og granuler med kontrollert frigivelsesformulering omfattende det samme
CR7198A (es) Tableta que contiene cetirizina y pseudoefedrina
NO20060669L (no) Modafinilsammensetninger
SE0300105D0 (sv) Diarylmethylidene piperdine derivatives, preparations thereof and uses thereof

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application